ENTX: Entera Bio Ltd. Stock

by  •  • Comments Off on ENTX: Entera Bio Ltd. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 70.96
Enterprise Value ($M) 59.94
Book Value ($M) 10.39
Book Value / Share 0.29
Price / Book 6.83
NCAV ($M) 9.88
NCAV / Share 0.28
Price / NCAV 7.18

Profitability (mra)
Return on Invested Capital (ROIC) -0.82
Return on Assets (ROA) -0.77
Return on Equity (ROE) -0.88

Liquidity (mrq)
Quick Ratio 10.32
Current Ratio 10.32

Balance Sheet (mrq) ($M)
Current Assets 11.26
Assets 11.77
Liabilities 1.38
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -8.89
Net Income -8.89
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -7.31
Cash from Investing -0.02
Cash from Financing 6.04

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
01-16 13G/A Knoll Capital Management, LLC 9.97 56.26

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-08 10-K UNITED STATES
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT
2023-08-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT T
2023-05-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 36,564 117,903 31.01
2024-04-25 13,482 34,074 39.57
2024-04-24 40,116 41,552 96.54
2024-04-23 34,285 22,588 151.78

(click for more detail)

Similar Companies
ELUT – Elutia Inc. ENLV – Enlivex Therapeutics Ltd.
ENSC – Ensysce Biosciences, Inc. ENVB – Enveric Biosciences, Inc.
EPIX – ESSA Pharma Inc.


Financial data and stock pages provided by
Fintel.io